This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Nice, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Hervé Chneiweiss: Innovator in Oncology
Introduction
Hervé Chneiweiss is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in oncology. His work focuses on developing new compounds that can aid in the treatment of various cancers.
Latest Patents
Hervé Chneiweiss holds a patent for "Neomycin based compounds, and pharmaceutical use thereof." This invention relates to the field of medicine, specifically oncology. It provides new compounds that are useful in treating various cancers, including glioblastoma, colorectal, and breast cancers. The patent also includes pharmaceutical compositions containing these disclosed compounds.
Career Highlights
Throughout his career, Hervé Chneiweiss has worked with prestigious institutions such as Université Côte d'Azur and the Centre National de la Recherche Scientifique. His research has contributed to advancements in cancer treatment and has the potential to improve patient outcomes.
Collaborations
Hervé Chneiweiss has collaborated with notable colleagues, including Thierry Virolle and Maria Duca. These partnerships have enhanced his research and development efforts in the field of oncology.
Conclusion
Hervé Chneiweiss is a prominent figure in the field of oncology, with a focus on innovative treatments for cancer. His patent and collaborations reflect his commitment to advancing medical science and improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile